Suppr超能文献

韩国免疫球蛋白G4相关疾病患者中的恶性肿瘤

Malignancies in Korean patients with immunoglobulin G4-related disease.

作者信息

Ahn Sung Soo, Song Jason Jungsik, Park Yong-Beom, Lee Sang-Won

机构信息

Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.

出版信息

Int J Rheum Dis. 2017 Aug;20(8):1028-1035. doi: 10.1111/1756-185X.13093. Epub 2017 May 22.

Abstract

AIM

Several studies have implicated increased risk of malignancy in patients with immunoglobulin G4-related disease (IgG4-RD). Hence, we first evaluated the risk and the type of malignancy in Korean IgG4-RD patients.

METHOD

Clinical and laboratory results of patients fulfilling the comprehensive diagnostic criteria for IgG4-RD were retrospectively collected between January 2006 and November 2015. One hundred and eighteen patients were included, and 35 were classified as having definite, 83 as possible/probable IgG4-RD. We compared baseline clinical and laboratory variables between patients with definite and those with possible/probable IgG4-RD and calculated standardized incidence ratios (SIRs) for malignancies.

RESULTS

The median age was 60 years old and 91 patients (77.1%) were male. Malignancies were found in 12 of 118 patients (10.1%), and lymphoma (4, 25.0%) was the most frequent malignancy related to IgG4-RD. Definite IgG4-RD patients had higher serum IgG levels and frequent multiple organ involvement. The overall incidence of malignancy was increased in patients with IgG4-RD compared to the general population (SIR 23.08 [95% CI 11.92-40.31]), and the overall risk of SIRs was highest in non-Hodgkin lymphoma (SIR 400.00 [95% CI 109.00-1024.00]).

CONCLUSION

Our data showed that increased risk of malignancy, especially lymphomas, was observed in Korean IgG4-RD patients.

摘要

目的

多项研究表明免疫球蛋白G4相关疾病(IgG4-RD)患者发生恶性肿瘤的风险增加。因此,我们首先评估了韩国IgG4-RD患者发生恶性肿瘤的风险及类型。

方法

回顾性收集2006年1月至2015年11月期间符合IgG4-RD综合诊断标准患者的临床和实验室检查结果。纳入118例患者,其中35例被分类为确诊的IgG4-RD,83例为可能/疑似IgG4-RD。我们比较了确诊患者与可能/疑似IgG4-RD患者的基线临床和实验室变量,并计算了恶性肿瘤的标准化发病比(SIRs)。

结果

患者中位年龄为60岁,91例(77.1%)为男性。118例患者中有12例(10.1%)发生恶性肿瘤,淋巴瘤(4例,25.0%)是与IgG4-RD相关最常见的恶性肿瘤。确诊的IgG4-RD患者血清IgG水平较高且常累及多个器官。与普通人群相比,IgG4-RD患者恶性肿瘤的总体发病率增加(SIR 23.08 [95% CI 11.92 - 40.31]),非霍奇金淋巴瘤的SIR总体风险最高(SIR 400.00 [95% CI 109.00 - 1024.00])。

结论

我们的数据显示,韩国IgG4-RD患者发生恶性肿瘤尤其是淋巴瘤的风险增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验